AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Exploring Antibodies Targeting Untapped Epitopes and Novel Bi-Specific Antibody for Inflammatory Disorders
Exploring antibodies targeting non-overlapping regions of a protein's dark side could lead to novel avenues for influenza vaccine and therapeutic development. The chapter also introduces a Phase 1 clinical trial for a bi-specific antibody with potential for treating inflammatory disorders.